Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

---

February 2, 2015

Dear Friends,

Drugs that can cure hepatitis C virus (HCV) are on the market in some countries. But these drugs are unaffordable for most of the 150 million people living with hepatitis C globally --90% of whom live in resource-limited settings. Activism to overcome pricing and other barriers to treatment is urgently needed.

TAG is pleased to release Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries. This guide presents key strategies through real-world case studies, and shows how strategies used to combat the AIDS epidemic can be—and have been—adapted to increase HCV treatment access.

We hope you find this document useful in your global treatment advocacy work. Please share widely with relevant stakeholders.
 

Section One: Laying the Groundwork through Community Organizing

Section Two: Overcoming the Cost Barriers to HCV Treatment Access

Section Three: Collaborating with Researchers to Build Your Case for HCV Treatment Access

--
Karyn Kaplan
Director, International Hepatitis/HIV Policy & Advocacy
TAG
karyn.kaplan@treatmentactiongroup.org
 

---

ABOUT TAG’S HEPATITIS/HIV PROJECT

TAG’s Hepatitis/HIV Project draws from the core values and history of HIV activism, while incorporating hepatitis C–specific information into strategies targeting different constituencies, regions, and countries. The Hepatitis/HIV Project focuses on optimizing quality of, and broadening access to, HCV care and treatment for communities and individuals by continuing its domestic and international work with other activists, regulatory agencies, pharmaceutical companies, clinicians, and the patient community